Adicet Bio, Inc. (ACET) vs BRIACELL THERAP (BCTX)

Adicet Bio, Inc. and BRIACELL THERAP are both Biotechnology companies. Adicet Bio, Inc. and BRIACELL THERAP are of similar size ($28.6M and $27.3M). Across the 11 metrics below, BRIACELL THERAP leads on 7 and Adicet Bio, Inc. on 4.

Valuation

Metric ACET BCTX Biotechnology median
P/E n/m n/m 10.60
P/S 0.85 n/m 9.40
P/B 0.27 1.29 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.84 0.01 0.66
EV/Sales (2.19) n/m 9.02
Earnings yield (375.41%) (174.34%) (32.88%)
Free cash flow yield (259.25%) (145.86%) (23.13%)

Profitability

Metric ACET BCTX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (78.08%) (212.23%) (51.96%)
Return on assets (63.62%) (154.34%) (46.06%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET BCTX Biotechnology median
Revenue growth (TTM) 224.62% — 6.76%
EPS growth (last fiscal year) 20.35% 88.66% 29.88%
Revenue growth, 5-year CAGR 6.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACET BCTX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 6.71 2.76 4.97
Net debt to EBITDA 1.32 0.57 1.01

Dividend

Metric ACET BCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACET BCTX Biotechnology median
Market cap 27.33m 28.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack